Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Published 19/01/2023, 12:48
Updated 19/01/2023, 14:10
© Reuters. Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • Tricida, Inc. (NASDAQ: TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.
  • Huadi International Group Co., Ltd. (NASDAQ: HUDI) rose 26.7% to $7.16 in pre-market trading after gaining over 3% on Wednesday.
  • Starbox Group Holdings Ltd. (NASDAQ: STBX) shares rose 22.1% to $3.65 in pre-market trading after the company reported a rise in FY22 earnings.
  • AIM ImmunoTech Inc. (NYSE: AIM) shares rose 15.8% to $0.73 in pre-market trading after dropping 18% on Wednesday. AIM ImmunoTech recently entered into a sponsored collaborative clinical research agreement with Erasmus MC and AstraZeneca.
  • Zymeworks Inc. (NASDAQ: ZYME) rose 12% to $11.20 in pre-market trading.
  • Berkshire Grey, Inc. (NASDAQ: BGRY) shares rose 11.3% to $0.97 in pre-market trading after dropping 14% on Wednesday.
  • TransCode Therapeutics, Inc. (NASDAQ: RNAZ) rose 11% to $0.7680 in pre-market trading after jumping 15% on Wednesday. TransCode Therapeutics recently announced it received written authorization from the FDA that it may proceed with its First-in-Human Phase 0 clinical trial.
  • BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) rose 9.1% to $3.02 in pre-market trading after dropping 10% on Wednesday. BiondVax recently announced additional results from preclinical study showing SARS-COV-2 presence of in hamsters treated with BiondVax's NanoAb was below detectable levels.
  • CureVac N.V. (NASDAQ: CVAC) rose 8.4% to $10.28 in pre-market trading. UBS upgraded CureVac from Neutral to Buy and announced an $18 price target.
  • Humanigen, Inc. (NASDAQ: HGEN) rose 6.5% to $0.1683 in pre-market trading after dropping around 5% on Wednesday.
Losers
  • Ontrak, Inc. (NASDAQ: OTRK) fell 12.8% to $0.9762 in pre-market trading. Ontrak shares jumped 95% on Wednesday after the company announced new data showing a reduction in depression and anxiety symptoms for Ontrak Health's Wholehealth+ program members.
  • Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares fell 14.2% to $0.4712 in pre-market trading. Sigilon Therapeutics shares jumped 33% on Wednesday after Canaccord Genuity initiated coverage on the stock with a Buy rating and a $6 price target.
  • Olink Holding AB (NASDAQ: OLK) shares fell 11.3% to $21.34 in pre-market trading after the company announced pricing of public offering of 5,831,028 American Depositary Shares at a price of $20 per ADS.
  • Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) fell 10% to $18.55 in pre-market trading after the company reported a $125 million proposed public offering of common stock.
  • TC Biopharm (Holdings) Plc (NASDAQ: TCBP) fell 9.5% to $5.70 in pre-market trading after gaining around 28% on Wednesday. TC BioPharm recently announced a strategic collaboration to advance gamma-delta T cells in oncology.
  • Magic Empire Global Limited (NASDAQ: MEGL) fell 9.2% to $2.75 in pre-market trading after jumping 44% on Wednesday.
  • ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) shares fell 8.2% to $2.36 in pre-market trading after dropping over 15% on Wednesday.
  • Veris Residential, Inc. (NYSE: VRE) fell 8.1% to $14.95 in pre-market after the company outlined path to unlocking shareholder value.
  • Vapotherm, Inc. (NYSE: VAPO) shares dropped 7.1% to $1.45 in pre-market trading after dropping 14% on Wednesday.
  • Alcoa Corporation (NYSE: AA) fell 6.5% to $49.96 in pre-market trading after the company reported quarterly results and issued weak guidance.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.